Current View
Click here to download the PDF file.

John Jefferson Perry, Assistant Professor of Biochemistry, University of California, Riverside and International Adjunct Professor, School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, received a grant from the Congressionally Directed Medical Research Programs, or CDMRP, of the US Department of Defense to develop a novel lead compound to treat breast cancer. "Our goal is to bring to the clinic a novel lead compound that selectively targets breast cancer cells," Perry said.